The Use of Anabolic Androgenic Steroids: A Focus on Polypharmacy

    January 2018 in “ Medicinski pregled
    Božana Nikolić, Dušica Rakić
    Studysummary This review highlights the various nonmedical uses of anabolic androgenic steroids and associated polypharmacy, suggesting that preventing their abuse should be a public health priority, but it reports no new findings.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document discussed the nonmedical use of anabolic androgenic steroids (AAS) like testosterone and nandrolone, particularly in the context of polypharmacy, where users combine these steroids with other pharmacological agents to enhance physical performance and manage side effects. This practice was prevalent among various social groups, including athletes and individuals involved in criminal activities. The combination of AAS with substances like growth hormone, insulin, clenbuterol, and diuretics aimed to boost anabolic effects, reduce body fat, and improve muscle definition, while other drugs were used to mask doping or manage adverse effects. The document highlighted the increased risk of adverse effects and withdrawal syndrome due to supraphysiological doses and polypharmacy, emphasizing the need for public health measures to prevent the nonmedical use of AAS.
    Discuss this study in the Community →